AlphaQuest’s Y-mAbs Therapeutics YMAB Stock Holding History

AlphaQuest’s Portfolio YMAB Stock Details YMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-38,925	Closed	-$176K	–	2291
2025 Q2	$176K	Hold	38,925	–	–	0.02%	1208
2025 Q1	$172K	Buy	38,925 +11,790	+43%	+$68.4K	0.02%	1055
2024 Q4	$212K	Buy	27,135 +26,748	+6,912%	+$326K	0.03%	847
2024 Q3	$5.09K	Buy	387 +386	+38,600%	+$4.89K	﹤0.01%	1580
2024 Q2	$12	Buy	+1	New	+$14	﹤0.01%	1541

Other funds holding YMAB

BIG

Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AlphaQuest's YMAB Position: Q3 2025 in Review

AlphaQuest sold out of Y-mAbs Therapeutics (YMAB) in Q3 2025, closing a stake of 38,925 shares — an estimated $176K sold.

AlphaQuest first reported a position in YMAB in Q2 2024 and held it in 5 quarters. The position peaked at $212K in Q4 2024. 2 funds tracked by Wall St. Rank hold YMAB as of Q3 2025.

AlphaQuest reported no remaining Y-mAbs Therapeutics position as of Q3 2025 after selling out during the quarter.
AlphaQuest sold 38,925 Y-mAbs Therapeutics shares in Q3 2025, an estimated $176K.
AlphaQuest first reported a position in Y-mAbs Therapeutics in Q2 2024 and held it in 5 quarters.
AlphaQuest's Y-mAbs Therapeutics position peaked at $212K in Q4 2024.
2 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q3 2025.

Based on AlphaQuest's 13F filing for Q3 2025, filed 3 Nov 2025.